Biological Therapy Analysis & Statistics, July 2014 (p4)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: stem cell, tissue engineering, cell therapy, more »

91-120 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 252 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 246 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 287 companies plus partners developing 411 TGF-beta receptor pathway targeting drugs in 1411 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 366 companies plus partners developing 550 TNF-alpha pathway targeting drugs in 2048 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 179 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
Immunotherapy in Oncology: Drug Pathway Analyzer 2014

Immunotherapy in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 811 immunotherapy drugs known to affect more than 234 specific intracellular signaling pathways for the ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

  • Industries : Biological Therapy
Anti GM-CSF Antibody -Pipeline Insights, 2014

Anti GM-CSF Antibody -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Anti GM-CSF Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

Broad Spectrum Chemokine Inhibitors (BSCIs) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Broad Spectrum Chemokine Inhibitors (BSCIs)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“B-Cell Activating Factor (BAFF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
CD4+ T cell Activators -Pipeline Insights, 2014

CD4+ T cell Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CD4+ T cell Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
CD8+ T cell Activators -Pipeline Insights, 2014

CD8+ T cell Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CD8+ T cell Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biological Therapy
Chemokine Receptor Antagonists -Pipeline Insights, 2014

Chemokine Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2014

G-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“G-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Biological Therapy
Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Opexa - Investor Report, October 2014

  • Opexa Therapeutics, Inc.
  • October 2014
    37 pages
  • Biological Ther...  

    Drug Discovery ...  

  • World  

View report >

Ethanol Supply In The Us

September 2014

33 Companies

Read our Company Profiles

StemCells Inc.

United States

Bioheart Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.